Guang-Yi Ouyang

Taurocholic acid attenuates hepatic inflammation in MASH and modulates the PPARγ/NF-κB axis.

Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated steatotic liver disease, is characterized by hepatocellular injury, inflammation, and varying degrees of fibrosis. Nevertheless, effective pharmacological treatments remain limited. Bile acids act as importan...